Most Recent Articles by Florence Chaverneff, PhD
The FDA commissioned the report to provide an update on current evidence on research, care, and education in the pain field, and to identify actionable measures for the FDA to more adequately address the ongoing opioid epidemic.
The recently released CDC guidelines on opioid prescribing remain a topic of debate.
Cannabis health end points include therapeutic effects, cardiometabolic risk, mental health, respiratory disease, and substance abuse.
The toolkit will provide healthcare professionals with adequate tools to manage their patients' pain.
Guidelines created in response to the opioid epidemic in the United States have caused controversy in the medical community.